SEC Form 4 · accession 0001209191-18-048708
Iterum Therapeutics plc · ITRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael W. Dunne
Officer — Chief Scientific Officer
Period of report
Aug 24, 2018
Accepted (ET)
Aug 28, 2018 · 5:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001659323
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Aug 24, 2018 | P | 500 | $10.00 | A | 146,958 | D | |
| Ordinary Shares | Aug 27, 2018 | P | 500 | $10.00 | A | 147,458 | D |
Table II — derivative securities
No Table II lines on this filing.